Expert review of precision medicine and drug development
about
Use of big data in drug development for precision medicine.Technological advances in precision medicine and drug development.Challenges influencing next generation technologies for precision medicine.A review of drugs in development for the personalized treatment of head and neck squamous cell carcinoma.Efficacy of lumacaftor-ivacaftor for the treatment of cystic fibrosis patients homozygous for the F508del-CFTR mutation.Radiomics: a new application from established techniques.PRECISION MANAGEMENT OF LOCALIZED PROSTATE CANCER.Genomic-based diagnosis of arrhythmia disease in a personalized medicine era.Personalized management of asthma exacerbations: lessons from genetic studies.Tissue-based biomarkers in prostate cancer.Towards precision medicine in Alzheimer's disease: deciphering genetic data to establish informative biomarkers.Recent progress in the use and tracking of transplanted islets as a personalized treatment for type 1 diabetes.The role of epigenomics in personalized medicine.The economic case for precision medicine.Progress towards precision medicine for lupus: the role of genetic biomarkersStructural brain network architecture and personalized medicine in epilepsyPrecision medicine to change the landscape of cardiovascular drug development‘You-on-a-chip’ for precision medicineCurrent approaches and future perspectives on strategies for the development of personalized tissue engineering therapiesMicroRNA-profiles in lung adenocarcinomasThe role of artificial intelligence in precision medicinePrecision medicine for multiple sclerosis: an update of the available biomarkers and their use in therapeutic decision makingNon-small cell lung cancer biomarkers and targeted therapy - two faces of the same coin fostered by nanotechnologyThe value of genetic risk scores in precision medicine for diabetesDeep learning and radiomics in precision medicineDecoupling knowledge and expertise in personalized medicine: who will fill the gap?Pharmacogenomic studies of hypertension: paving the way for personalized antihypertensive treatmentObstructive sleep apnea: in search of precisionEpigenetic inhibitors for the precision treatment of ARID1A-mutant ovarian cancers: what are the next steps?Nab-paclitaxel and atezolizumab for the treatment of PD-L1-positive, metastatic triple-negative breast cancer: review and future directionsThe genetic risk of second cancers: should the therapy for acute lymphoblastic leukemia be individualized according to germline genetic makeup?Leaving some behind: the growing gap in precision medicine for minority populationsTRAIL pathway targeting therapeuticsUse of big data in drug development for precision medicine: an updateIntegrating pharmacogenetic testing into primary careImmunotherapy and next-generation sequencing guided therapy for precision oncology: What have we learnt and what does the future hold?Privacy and ethical challenges in next-generation sequencing
P1433
Q31115480-8E49149B-CABB-41B6-A553-128A64316316Q37244501-7D242E24-D543-4BDD-A7E6-6B3C2AC82EB0Q37514322-EE6B0DA4-32B7-4340-BC08-BB6C8764A300Q37669978-61528942-EBB9-4F91-ADD6-C05001C7472FQ38835405-06150775-AF75-4C57-8086-A06847F3912FQ39044635-C1DF5547-47EB-4F8F-BB91-583B53F61F4DQ39108592-62F19E84-FC9A-4AED-B091-9A6DFDDC3E2AQ46129436-ED7B0A85-F590-4693-8DA5-94E8A013DC90Q47139159-F87D17B2-EBD2-4A40-95F1-B3F6A966D616Q47144748-5AF6C26D-59A9-4EA2-A8D2-F11078F14F59Q47929398-AC57A8FF-0068-488B-AB0F-6991DA52A51AQ48510837-D21F8536-F83A-49BB-9F56-A9DE034D1836Q49584264-86D39DFF-6116-4B85-9032-76D22CD81DCFQ55217201-8260AFBB-340D-49C4-876E-0C15C1568595Q56451746-771080FF-BF65-4A5C-BF66-3712306D4698Q57724572-2BB9C2F7-96C4-4E6E-9E98-86E92557016CQ60514264-D92F8E62-3D27-42A7-BE55-2428E2456D40Q60660553-43E329BD-A1DE-41BF-8892-675528B3775AQ60733251-0C5973EA-BFE6-4FA5-AC1D-09A00E59E244Q61051587-6CDADF88-4898-437A-9C78-7B22FFE98B60Q61661590-9703148B-F2BA-455F-9FDE-1A3EB3C33466Q61756974-1DE845E8-2C8F-44B3-8655-F30D4C89A810Q61770892-2A6340D8-7F39-42ED-B484-7B72A91096C4Q63916432-454FF07E-6FA3-4A4A-B6BD-E8CE7BBD0757Q64100588-029AE2F5-5415-4EB7-8D21-CBA60C47D6EDQ73169775-8F85E84F-1C9A-4047-83E9-AB0D1B033143Q89058282-655490FF-F9C3-47F7-AE39-BCDAE6CC3F13Q90245623-9667E4F2-F96B-40DB-B946-6DB4562B79B9Q90328022-2999C6DF-EED2-46DF-9059-4358D0763A12Q90451865-B82C8AB1-0029-4EA7-B7CD-5C6EE1A12181Q90599688-4A1DCE50-44A9-461B-873C-C5B8524A354DQ91085305-CEE7E930-A028-4BB5-8C7D-08BB257EF665Q91443549-B48BF60F-9B7B-4290-8219-A6A233EDB190Q91727289-1B88472A-E648-40B9-9DBD-15E3F8AD9FA4Q92102522-1E365349-1109-432A-9293-1EEAF4B36C73Q92315030-BE34E158-08A8-41F3-BBBD-1BCBAE36E4FCQ95584922-29B687D1-3C05-4196-BBDD-73B0D83598F5
P1433
Expert review of precision medicine and drug development
description
czasopismo naukowe
@pl
journal
@en
revista científica
@es
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Expert review of precision medicine and drug development
@ast
Expert review of precision medicine and drug development
@en
Expert review of precision medicine and drug development
@es
Expert review of precision medicine and drug development
@nl
type
label
Expert review of precision medicine and drug development
@ast
Expert review of precision medicine and drug development
@en
Expert review of precision medicine and drug development
@es
Expert review of precision medicine and drug development
@nl
altLabel
Expert Rev Precis Med Drug Dev
@en
prefLabel
Expert review of precision medicine and drug development
@ast
Expert review of precision medicine and drug development
@en
Expert review of precision medicine and drug development
@es
Expert review of precision medicine and drug development
@nl
P1055
P1156
21100860941
P1476
Expert review of precision medicine and drug development
@en